CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 56 enrolled
Drug / intervention
Belladonna Opium +1 moredrug
Likely dose
Belladonna Opium 60mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03657407
NCT03657407Phase 4Completed
CompareCT.gov

Belladonna and Opium Rectal Suppository Effect on Postoperative Pain and Nausea Following Total Laparoscopic and Robotic-Assisted Hysterectomy

Anna Reinert·interventional·Posted Sep 5, 2018·Updated Apr 2, 2019

In Brief

A Phase 4 clinical trial evaluating Belladonna Opium and Glycerin Suppository for Hysterectomy and Pain, Postoperative. Completed, enrolled 56 participants across 1 site.

Detailed Summary

A prospective, single-center, double-blind, randomized, placebo-controlled trial to assess the impact of immediate post-operative placement of a Belladonna and Opium (B\&O) rectal suppository on postoperative pain and nausea following laparoscopic and robot-assisted hysterectomy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHysterectomy, Pain, Postoperative
CountriesUnited States
CollaboratorsUniversity of Maryland

Timeline

Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedSep 5, 2018
Enrollment StartJun 1, 2016
Primary CompletionMay 31, 2017
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 7.8 years ago

Interventions

Belladonna Opiumdrug

Belladonna Opium 16.2-60mg rectal suppository

Glycerin Suppositorydrug

Glycerine rectal suppository